CPC A61K 9/127 (2013.01) [A61K 9/0019 (2013.01); A61K 9/1277 (2013.01); A61K 31/337 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61K 47/28 (2013.01)] | 5 Claims |
1. A pharmaceutical liposomal composition consisting of comprising
(a) about 0.8% w/w to about 1% w/w of docetaxel,
(b) about 30% w/w to about 38% w/w of Soya Phosphatidyl Choline,
(c) about 0.2% w/w to about 0.8% w/w of Sodium Cholesteryl Sulfate,
(d) about 61% w/w to about 68% w/w of Sucrose and
(e) a pH adjusting agent,
wherein the pH of liposomal composition is less than 3.5 and wherein the liposomal composition is prepared by a process of dispersing Soya Phosphatidyl Choline in solvent mixture of methanol and tertiary butanol in the ratio of 1:1.
|